U.S. pharma big copyright scrapped two experimental weight loss capsules very last yr—a once-everyday capsule, lotiglipron, due to elevated liver enzymes and also a twice-day-to-day tablet, danuglipron, resulting from strong Unintended effects—but CEO Albert Bourla has mentioned the company is decided to “Perform and win” from the weight pr